{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:44:37Z","timestamp":1774057477620,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:00:00Z","timestamp":1484956800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(81473138)"],"award-info":[{"award-number":["(81473138)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Frontier & Key Technology Innovation Program","award":["(2015B010109004)"],"award-info":[{"award-number":["(2015B010109004)"]}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["(2016A030310228)"],"award-info":[{"award-number":["(2016A030310228)"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Province Key Lab. Construction Foundation","award":["(2011A060901014)"],"award-info":[{"award-number":["(2011A060901014)"]}]},{"name":"Collaborative Innovation Center of HPC, NUDT, Changsha"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Small molecule drug candidates with attractive toxicity profiles that modulate target proteins through non-covalent interactions are usually favored by scientists and pharmaceutical industry. In the past decades, many non-covalent binding agents have been developed for different diseases. However, an increasing attention has been paid to covalent binding agents in pharmaceutical fields during recent years. Many covalent binding agents entered clinical trials and exerted significant advantages for diseases such as infection, cancers, gastrointestinal disorders, central nervous system or cardiovascular diseases. It has been recognized that covalent binding ligands can be attractive drug candidates. But, there is lack of resource to support covalent ligand discovery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Hence, we initiated a covalent binder database (cBinderDB). To our best knowledge, it is the first online database that provides information on covalent binding compound structures, chemotypes, targets, covalent binding types and other biological properties. The covalent binding targets are annotated with biological functions, protein family and domains, gene information, modulators and receptor\u2013ligand complex structure. The data in the database were collected from scientific publications by combining a text mining method and manual inspection processes. cBinderDB covers covalent binder\u2019s data up to September 2016.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and Implementation<\/jats:title>\n                  <jats:p>cBinderDB is freely available at www.rcdd.org.cn\/cbinderdb\/<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary information<\/jats:title>\n                  <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btw801","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T20:05:18Z","timestamp":1481659518000},"page":"1258-1260","source":"Crossref","is-referenced-by-count":26,"title":["cBinderDB: a covalent binding agent database"],"prefix":"10.1093","volume":"33","author":[{"given":"Jiewen","family":"Du","sequence":"first","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Xin","family":"Yan","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Lu","family":"Cui","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Peng","family":"Ding","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Xiaoqing","family":"Tan","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Xiuming","family":"Li","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Huihao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Qiong","family":"Gu","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[{"name":"Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China"}]}],"member":"286","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"2023020205031514100_btw801-B1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/17460441.2016.1115478","article-title":"New drug design with covalent modifiers","volume":"11","author":"Adeniyi","year":"2016","journal-title":"Exp. Opin. Drug Discov"},{"key":"2023020205031514100_btw801-B2","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1021\/jm3003203","article-title":"Irreversible protein kinase inhibitors: balancing the benefits and risks","volume":"55","author":"Barf","year":"2012","journal-title":"J. Med. Chem"},{"key":"2023020205031514100_btw801-B3","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","author":"Bateman","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","article-title":"Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies","volume":"20","author":"Bauer","year":"2015","journal-title":"Drug Discov. Today"},{"key":"2023020205031514100_btw801-B5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nchembio.1817","article-title":"Prolonged and tunable residence time using reversible covalent kinase inhibitors","volume":"11","author":"Bradshaw","year":"2015","journal-title":"Nat. Chem. Biol"},{"key":"2023020205031514100_btw801-B6","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B7","doi-asserted-by":"crossref","first-page":"D492","DOI":"10.1093\/nar\/gkp858","article-title":"The NCBI BioSystems database","volume":"38","author":"Geer","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B8","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cmdc.201500469","article-title":"Designing irreversible inhibitors\u2013worth the effort?","volume":"11","author":"Gonzalez-Bello","year":"2016","journal-title":"ChemMedChem"},{"key":"2023020205031514100_btw801-B10","doi-asserted-by":"crossref","first-page":"D1079","DOI":"10.1093\/nar\/gku1071","article-title":"Genenames.org: the HGNC resources in 2015","volume":"43","author":"Gray","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B11","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pharmtox-010814-124401","article-title":"The design of covalent allosteric drugs","volume":"55","author":"Nussinov","year":"2015","journal-title":"Annu. Rev. Pharmacol"},{"key":"2023020205031514100_btw801-B13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1021\/jm8008597","article-title":"Covalent modifiers: an orthogonal approach to drug design","volume":"52","author":"Potashman","year":"2009","journal-title":"J. Med. Chem"},{"key":"2023020205031514100_btw801-B14","doi-asserted-by":"crossref","first-page":"D345","DOI":"10.1093\/nar\/gku1214","article-title":"The RCSB Protein Data Bank: views of structural biology for basic and applied research and education","volume":"43","author":"Rose","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023020205031514100_btw801-B15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023020205031514100_btw801-B16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/ci950061u","article-title":"GMA: a generic match algorithm for structural homomorphism, isomorphism, and maximal common substructure match and its applications","volume":"36","author":"Xu","year":"1996","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"2023020205031514100_btw801-B17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11030-012-9403-0","article-title":"GSA: a GPU-accelerated structure similarity algorithm and its application in progressive virtual screening","volume":"16","author":"Yan","year":"2012","journal-title":"Mol. Divers"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/33\/8\/1258\/49038939\/bioinformatics_33_8_1258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/33\/8\/1258\/49038939\/bioinformatics_33_8_1258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T05:07:42Z","timestamp":1675314462000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/33\/8\/1258\/2736369"}},"subtitle":[],"editor":[{"given":"Jonathan","family":"Wren","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btw801","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4,15]]},"published":{"date-parts":[[2016,12,30]]}}}